European stock markets commenced the trading week on a weaker footing Monday, retreating from recent gains as fresh tariff ...

Futures on Wall Street have begun trading on Sunday evening US time on a negative note amidst rising uncertainties on trade ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its position in ...

Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline ...

(Reuters) -European shares opened lower on Monday, after rounding off monthly gains in May, as U.S. President Donald Trump's ...

President Trump said Friday that tariffs on imported steel and aluminum would increase to 50% from 25%, effective Wednesday. Australian investment manager Washington H. Soul Pattinson and ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Sanofi agreed to buy Blueprint Medicines, a U.S. pharmaceutical company that specializes in rare immunological diseases, for up to $9.5 billion in a deal that seeks to strengthen the French ...

Sanofi SA will buy Blueprint Medicines Corp. for $9.1 billion equity value, in a deal that sees the European pharmaceutical ...

French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation , a biopharmaceutical company ...